As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
Unified Machine Readable Target Data Models from Smart Transformer of Disparate Biopharma Source Data
Whitepaper - June 20, 2019 read more
Unlocking Insights: Cross-Study Analysis of SEND Datasets with Xbiomâ„¢
For those who couldn't join us live, we're excited to share the recording of our third SEND webinar! This... read more
Webinar: Ensuring 100% Submission Data Quality with SEND ASSURE
Date: Wednesday, May 28, 2025 Time: 9:00 AM PT | 12:00 PM ET https://youtu.be/lC7Qtd_YSrY?si=UXN18e5vQYdZTqa6 Most SEND preparers (CROs, Vendors, In-house) perform spot-checks,... read more
Beginning on September 15, 2021, FDA will begin enforcing the Technical Rejection Criteria (TRC).
FDA to enforce the Technical Rejection Criteria (TRC) beginning Sept 15th, 2021 (Â Technical Rejection Criteria for Study Data) The TRC has... read more
